4.5 Article

Synthesis, antimicrobial and anticancer activities of Tetronic 1107 Schiff bases

Journal

POLYMERS FOR ADVANCED TECHNOLOGIES
Volume 33, Issue 9, Pages 2787-2797

Publisher

WILEY
DOI: 10.1002/pat.5732

Keywords

antimicrobial materials and anticancer materials; poloxamines; Schiff base; Tetronic 1107

Funding

  1. King Saud University, Riyadh, Saudi Arabia [RSP-2021/259]

Ask authors/readers for more resources

Due to the seriousness of bacterial infections, it is necessary to improve antimicrobial polymers to overcome the limitations of conventional antimicrobial agents. This study successfully modified a polymer to enhance its biological activities and found potential antimicrobial and anticancer effects.
As a result of the serious issues connected to the bacterial infections, there is an imperious need to improve strong and ecofriendly antimicrobial polymers to overcome the limitations of conventional antimicrobial agents. In this trend, poloxamines (Tetronics) which are X-shaped poly(ethylene oxide)-poly(propylene oxide) diblocks linked to a focal ethylenediamine group; were successfully modified to produce Tetronic Schiff base for enhancing the biological activities of Tetronic 1107. Modification of tetronic 1107 (T1107) was proceeded throughout chloroacetylation of T1107 followed by amination using p-phenylenediamine then the latter was treated with different aldehydes to yield Tetronic Schiff bases. Characterization of Tetronic Schiff bases was carried out by H-1-NMR, Fourier-transform infrared spectroscopy, X-ray diffraction, elemental analysis and thermogravimetric analysis (TGA) analyses. The antimicrobial activities of four tested compounds coded (EK1, EK2, EK3, and EK4) were quantified using Microtiter-assay methods. The obtained data revealed potential antimicrobial activities for tested compounds against all tested microbes with priority against Pseudomonas aeruginosa, Escherichia coli and Staphylococcus aureus. Sample coded EK4 exhibited the most effective treatment against P. aeruginosa, Candida albicans, S. aureus and E. Coli with minimal inhibitory concentration values of 6, 16, 12.5, and 1.5 mu M, respectively. Furthermore, the safety results confirmed that EK4 and EK1 were the safest treatment with IC50 values of 76.01 and 62.67 mu M, respectively. In addition, all tested compounds showed significant anticancer effects against MDA-MB-231cell line, while EK3 was effective treatment against A549 cell line with IC50 values of 39.63 mu M. Meanwhile, both EK2 and EK4 showed the highest selectivity index (SI) values against MDA-MB-231 cell line with values 2.5 and 3.07, respectively. Interestingly, EK4 showed the maximum SI values on A549 and Hep-G2 cell lines with values 1.62 and 1.52, respectively.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available